Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
| Autor: | Emkey, Ronald, Delmas, Pierre D., Bolognese, Michael, Borges, Joao Lindolfo C., Cosman, Felicia, Ragi-Eis, Sergio, Recknor, Christopher, Zerbini, Cristiano A., Neate, Colin, Sedarati, Farhad, Epstein, Solomon |
|---|---|
| Zdroj: | In Clinical Therapeutics April 2009 31(4):751-761 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect